CCL2 and systemic sclerosis: Based on these results, BM-MSC-CM and WJ-MSC-CM contained larger amounts of chemokines compared to AT-MSC-CM and CB-MSC-CM, especially those with angiogenic properties (SDF-1, IL-8, MCP-1), that could exert beneficial effects in treatment of vascular diseases, including SSc.